Don’t miss the latest developments in business and finance.

Orchid Pharma receives Establishment Inspection Report for formulations facility in Sriperumbudur

Image
Capital Market
Last Updated : Apr 19 2017 | 12:02 AM IST

From USFDA

Orchid Pharma has received Establishment Inspection Report from USFDA based on the successful inspection of the formulation manufacturing facility located at Sriperumbudur, Kancheepuram District, Tamil Nadu. The facility was inspected by USFDA in December 2016.

Powered by Capital Market - Live News

Also Read

First Published: Apr 18 2017 | 2:13 PM IST

Next Story